EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access

Antileishmanial Activity of Manganese (III) Oxide Nanoparticles (Mn2O3 NPs) Alone and in Combination with Shark Cartilage Extract against Leishmania infantum: in Vitro and in Vivo Approaches

Zahra Mashhadi, Alireza Ziyabakhsh, Negin Farrokhiasl, Fatemeh Ghaffarifar, Behnam Mohammadi-Ghalehbin, Shabnam Asfaram, Soheila Molaei

Iranian Journal of Parasitology · 20.07.2026

DOI: 10.18502/ijpa.v21i2.22087 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Iranian Journal of Parasitology, online erschienen am 20.07.2026. Verfasst von Zahra Mashhadi und 6 weiteren Autor:innen. Beteiligte Einrichtung: Students Research Committee, School of Medicine, Ardabil University of Medical Sciences, Ardabil, Iran. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

The recent increase in unresponsive cases to current treatments poses a significant challenge in the effort to discover new antileishmanial drugs. We aimed to investigate the effects of Mn2O3 NPs alone or in combination with shark cartilage extract (ShCE) on L. infantum (MCAN/ES198/LIM-877) both in vitro and in vivo.

Methods

The susceptibility of promastigotes and amastigotes was evaluated using MTT and microscopy assays with different concentrations of Mn2O3 NPs alone or in combination with ShCE (Mn2O3-ShCE). The combination index (CI) was used to assess potential synergy. Cytotoxicity against J774.A1 macrophages was measured, and the selectivity index (SI) was calculated. Also, apoptosis was analyzed in promastigotes. The therapeutic and prophylactic effects were tested in BALB/c mice, and survival rates were monitored.

Results

Mn2O3 NPs caused a dose-dependent decrease in proliferation of promastigotes (IC50=19.8±1.1 μg/mL) and amastigotes (IC50=29.9±0.05 μg/mL). Co‑treatment with ShCE significantly enhanced the antileishmanial activity, reducing the IC50 values of promastigotes and amastigotes. The CC50 values were 159.9±4.2 μg/mL for Mn2O3 NPs and 276.5±7.9 μg/mL for Mn2O3-ShCE. Apoptosis rates in promastigotes treated with Mn2O3 and Mn2O3-ShCE were 80.7% and 86.3%, respectively. Parasite loads in the tissues significantly decreased (P

Schlagwörter

Stichwörter der Autor:innen

In vitroIn vivoLeishmania infantumMn2O3 NPsShark cartilage extract

Autor:innen und Institutionen

  • Students Research Committee, School of Medicine, Ardabil University of Medical Sciences, Ardabil, Iran.
  • Deputy of Health, Ardabil University of Medical Sciences, Ardabil, Iran.
  • Department of Parasitology, Faculty of Medical Sciences, Tarbiat Modares University, Tehran, Iran.
  • Zoonoses Research Center, Ardabil University of Medical Sciences, Ardabil, Iran.

Zitieren

APA

Mashhadi, Z., Ziyabakhsh, A., Farrokhiasl, N., Ghaffarifar, F., Mohammadi-Ghalehbin, B., Asfaram, S., & Molaei, S. (2026). Antileishmanial Activity of Manganese (III) Oxide Nanoparticles (Mn2O3 NPs) Alone and in Combination with Shark Cartilage Extract against Leishmania infantum: in Vitro and in Vivo Approaches. Iranian Journal of Parasitology. https://doi.org/10.18502/ijpa.v21i2.22087

Vancouver

Mashhadi Z, Ziyabakhsh A, Farrokhiasl N, Ghaffarifar F, Mohammadi-Ghalehbin B, Asfaram S, et al. Antileishmanial Activity of Manganese (III) Oxide Nanoparticles (Mn2O3 NPs) Alone and in Combination with Shark Cartilage Extract against Leishmania infantum: in Vitro and in Vivo Approaches. Iranian Journal of Parasitology. 2026. doi:10.18502/ijpa.v21i2.22087

BibTeX
@article{Mashhadi2026,
  author = {Mashhadi, Zahra and Ziyabakhsh, Alireza and Farrokhiasl, Negin and Ghaffarifar, Fatemeh and Mohammadi-Ghalehbin, Behnam and Asfaram, Shabnam and Molaei, Soheila},
  title = {Antileishmanial Activity of Manganese (III) Oxide Nanoparticles (Mn2O3 NPs) Alone and in Combination with Shark Cartilage Extract against Leishmania infantum: in Vitro and in Vivo Approaches},
  journal = {Iranian Journal of Parasitology},
  year = {2026},
  doi = {10.18502/ijpa.v21i2.22087}
}
Kostenlos starten →